AIM: 131I-meta-iodobenzylguanidine (131I-MIBG) therapy has been used in neuroblastoma treatment for many years but its value in high intensive first line treatment protocols is not exactly known...
Keywords: Hochrisiko-Neuroblastom, Neuroblastom Stadium 4, 131I-MIBG-Therapie
01/2006 | Nuklearmedizin, Schattauer